17 Dec 2017 TECHINSA Awards Early Stage Commercialisation Grant to GPN Vaccines
The South Australian Early Commercialisation Fund administered by TechInSA has awarded GPN Vaccines $300,000....
The South Australian Early Commercialisation Fund administered by TechInSA has awarded GPN Vaccines $300,000....
The National Health and Medical Research Council of Australia has awarded $955,000 to the Univesity of Adelaide & GPN Vaccines to develop a universal pneumococcal vaccine....
Gamma Vaccines creates GPN Vaccines Pty Ltd as vehicle to develop its universal pneumococcal vaccine. [Download]...